Description

Mofebutazone is a non-steroidal anti-inflammatory drug (NSAID) belonging to the pyrazolidine class, known for its analgesic and antipyretic properties. This compound is a critical pharmaceutical intermediate for the synthesis of more complex anti-inflammatory agents. It is primarily utilized by pharmaceutical manufacturers and research institutions in the development and production of therapeutic formulations targeting pain and inflammation management.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of advanced NSAIDs and other anti-inflammatory medications.
• Analgesic Drug Development: Used in research and production of drugs aimed at relieving pain.
• Antipyretic Formulations: A component in the development of medications designed to reduce fever.
• Anti-inflammatory Research: Serves as a reference standard and active material in pharmacological studies for inflammation pathways.
• Veterinary Medicine: Potential use in the formulation of anti-inflammatory treatments for animals.
• Chemical Reference Standard: Used in analytical laboratories for method development, validation, and quality control testing.

Basic Information

Product Name	Mofebutazone
CAS No.	2210-63-1
Molecular Formula	C₁₅H₂₀N₂O₂
Molecular Weight	260.33 g/mol
Synonyms	4-Butyl-1-phenyl-3,5-pyrazolidinedione; Monobutylone; Mofebutazone; Phenylbutazone Impurity A; 1-Phenyl-4-butyl-3,5-pyrazolidinedione; 4-n-Butyl-1-phenyl-3,5-pyrazolidinedione; CL-369; NSC-403697
EINECS	218-656-7

Quality Control

Our Mofebutazone is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity standards suitable for pharmaceutical research and development. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥98.0%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%
Related Substances (HPLC)	Individual impurity ≤0.5%; Total impurities ≤1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.